当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析 - 现金流量表

南微医学

(688029)

  

流通市值:157.04亿  总市值:157.04亿
流通股本:1.88亿   总股本:1.88亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,496,182,491.911,670,186,983.86739,607,987.832,780,267,748.16
  收到的税费返还9,697,086.119,275,495.948,558,355.834,044,451.29
  收到其他与经营活动有关的现金60,553,645.237,317,413.3316,037,934.9248,334,913.53
  经营活动现金流入小计2,566,433,223.221,716,779,893.13764,204,278.582,832,647,112.98
  购买商品、接受劳务支付的现金897,431,648.8633,004,829.96320,406,653.47706,731,033.26
  支付给职工以及为职工支付的现金645,237,236.2451,599,293.4270,913,522.63732,834,529.14
  支付的各项税费162,546,731.197,204,782.0338,302,549.05211,333,149.23
  支付其他与经营活动有关的现金383,689,106.66232,788,536.0264,014,455.78568,726,513.27
  经营活动现金流出小计2,088,904,722.761,414,597,441.41693,637,180.932,219,625,224.9
  经营活动产生的现金流量净额477,528,500.46302,182,451.7270,567,097.65613,021,888.08
二、投资活动产生的现金流量:
  收回投资收到的现金861,470,111.64463,428,578.54301,539,221.672,103,745,914.08
  取得投资收益收到的现金24,923,086.622,241,842.98-56,801,217.46
  处置固定资产、无形资产和其他长期资产收回的现金净额153,627153,627100,0006,657,181.81
  收到的其他与投资活动有关的现金53,869,20053,869,200--
  投资活动现金流入小计940,416,025.24539,693,248.52301,639,221.672,167,204,313.35
  购建固定资产、无形资产和其他长期资产支付的现金210,279,742.27180,536,086.41116,319,150.23269,619,096.15
  投资支付的现金591,976,885.59128,841,574.0526,126,3001,470,915,734.33
  取得子公司及其他营业单位支付的现金240,301,599.84240,301,599.84240,301,599.843,407,949.38
  支付其他与投资活动有关的现金---10,893,817.7
  投资活动现金流出小计1,042,558,227.7549,679,260.3382,747,050.071,754,836,597.56
  投资活动产生的现金流量净额-102,142,202.46-9,986,011.78-81,107,828.4412,367,715.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,000,002.87,785,602.8--
  其中:子公司吸收少数股东投资收到的现金8,000,002.87,785,602.8--
  取得借款收到的现金190,000,00065,000,000--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计198,000,002.872,785,602.8--
  偿还债务支付的现金86,490,690.9186,830,966.113,337,572.42-
  分配股利、利润或偿付利息支付的现金280,480,889.05186,871,269.941,618,957.36283,419,575.67
  支付其他与筹资活动有关的现金21,026,107.578,636,539.63,341,088.8974,061,723
  筹资活动现金流出小计387,997,687.53282,338,775.6418,297,618.67357,481,298.67
  筹资活动产生的现金流量净额-189,997,684.73-209,553,172.84-18,297,618.67-357,481,298.67
四、汇率变动对现金及现金等价物的影响30,364,694.2857,358,248.0813,594,512.6-6,954,827.84
五、现金及现金等价物净增加额215,753,307.55140,001,515.18-15,243,836.82660,953,477.36
  加:期初现金及现金等价物余额1,870,216,138.21,870,216,138.21,870,216,138.21,209,262,660.84
  期末现金及现金等价物余额2,085,969,445.752,010,217,653.381,854,972,301.381,870,216,138.2
补充资料:
  净利润-379,758,886.04-568,077,232.03
  资产减值准备-9,266,509.45-56,873,239.97
  固定资产和投资性房地产折旧-35,139,816.17-47,637,571.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,139,816.17-47,637,571.9
  无形资产摊销-15,295,810.76-26,472,255.78
  长期待摊费用摊销-9,293,890.52-13,800,931.79
  处置固定资产、无形资产和其他长期资产的损失-7,425.13--722,720.64
  固定资产报废损失-174,424.23-208,693.54
  公允价值变动损失--403,050.42-472,933.8
  财务费用--55,312,344.2--29,817,557.17
  投资损失--6,222,947.56--20,504,100.32
  递延所得税--3,151,689.04--4,365,718.85
  其中:递延所得税资产减少--3,282,458.73--4,330,436.94
    递延所得税负债增加-130,769.69--35,281.91
  存货的减少--70,312,856.24--67,181,550.62
  经营性应收项目的减少--29,364,464.86--43,555,544.3
  经营性应付项目的增加-5,597,792.35-49,925,024.85
  其他-2,763,888.9--3,479,351.85
  现金的期末余额-2,010,217,653.38-1,870,216,138.2
  减:现金的期初余额-1,870,216,138.2-1,209,262,660.84
  现金及现金等价物的净增加额-140,001,515.18-660,953,477.36
公告日期2025-10-282025-08-122025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑